Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians

被引:6
作者
Wu, Tingfeng [1 ,5 ]
Ye, Junzhao [1 ]
Mo, Suilin [2 ,5 ]
Ye, Miaosheng [6 ]
Li, Xiaoyi [8 ]
Li, Qing [7 ]
Wang, Wengeng [10 ]
Zheng, Qiaocong [10 ,11 ]
Luo, Ke [9 ]
Zhang, Yi [14 ]
Tu, Shouwei [15 ]
Che, Daituan [12 ,16 ]
Gong, Rulong [12 ]
Chen, Xing [13 ]
Miu, Rong [3 ]
Shao, Congxiang [1 ]
Sun, Yanhong [4 ]
Zhong, Bihui [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, 58 Zhongshan II Rd, Guangzhou 510080, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Hlth Care Ctr, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hlth Care Ctr Huangpu, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Clin Labs, Guangzhou, Peoples R China
[5] Guangzhou Univ Tradit Chinese Med, Foshan Hosp Tradit Chinese Med, Dept Gastroenterol, Guangzhou, Peoples R China
[6] Guangdong Prov Peoples Hosp, Pingzhou Hosp, Dept Hlth Care Ctr, Guangzhou, Peoples R China
[7] South China Univ Technol, Nanhai Peoples Hosp, Dept Hlth Care Ctr, Foshan, Peoples R China
[8] Yunfu Peoples Hosp, Dept Hlth Care Ctr, Yunfu, Peoples R China
[9] Luoding Peoples Hosp, Dept Hlth Care Ctr, Yunfu, Peoples R China
[10] Lianzhou Peoples Hosp, Dept Hlth Care Ctr, Qingyuan, Peoples R China
[11] Yangjiang Peoples Hosp, Dept Hlth Care Ctr, Yangjiang, Peoples R China
[12] Yangdong Peoples Hosp, Dept Hlth Care Ctr, Yangjiang, Peoples R China
[13] Yangjiang Publ Hlth Hosp, Dept Hepatol, Yangjiang, Peoples R China
[14] Jieyang Peoples Hosp, Dept Hlth Care Ctr, Jieyang, Peoples R China
[15] Ruyuan Peoples Hosp, Dept Hlth Care Ctr, Shaoguan, Peoples R China
[16] Cent Peoples Hosp Zhanjiang, Dept Hlth Care Ctr, Zhanjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
metabolic associated fatty liver disease; nonalcoholic fatty liver disease; prevalence; steatotic liver disease; FATTY; MAFLD; NAFLD;
D O I
10.1111/jgh.16554
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim: The introduction of the latest nomenclature, metabolic associated steatotic liver disease (MASLD), proposed by the multi-society without Asian society consensus statement, aims to redefine the diagnostic criteria for metabolic associated fatty liver disease (MAFLD). However, its effect on the epidemiology in Asia remains unclear. Method: We conducted a population-based cross-sectional survey on fatty liver disease using multistage stratified random sampling of participants from Guangzhou, a representative area in China (ChiCTR2000033376). Demographic, socioeconomic, lifestyle, and laboratory data were collected. Hepatic steatosis and the severity of fibrosis were assessed using FibroScan. Results: A total of 7388 individuals were recruited, the proportion of which meeting the definitions for nonalcoholic fatty liver disease (NAFLD), MAFLD, and MASLD were 2359 (31.9%), 2666 (36.1%), and 2240 (30.3%), respectively. One hundred and twenty (1.6%) patients had cryptogenic SLD, and 537 (7.3%) patients were diagnosed with MetALD. MASLD did not significantly differ from NAFLD and MAFLD, except that MAFLD patients had a lower proportion of males, hypertension, and diabetes and were less likely to consume tea (P < 0.05). Both cryptogenic SLD and MASLD non-MAFLD patients exhibited milder hepatic steatosis and a lower frequency of liver injury than NAFLD, MAFLD, or MASLD patients (all P < 0.05). An increased HOMA-IR (adjusted OR: 1.33, 95% CI: 1.10-2.03) was associated with higher risk of moderate-to-severe steatosis for MASLD non-MAFLD patients, while consuming more cups of tea (P for trend = 0.015) showed inverse associations. Conclusion: Irrespective of terminology used is that fatty liver disease is highly prevalent in the Han Chinese population. Differences in insulin resistance and lifestyle risk factors are associated with redefinition disparities.
引用
收藏
页码:1636 / 1647
页数:12
相关论文
共 50 条
  • [1] Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
    Cheng, Yu-Ming
    Hsieh, Tsung-Han
    Wang, Shan-Wen
    Wang, Chia-Chi
    Kao, Jia-Horng
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 10 (04) : 249 - 256
  • [2] Psychosocial risks in metabolic dysfunction-associated steatotic liver disease
    Astrom, Hanne
    Takami Lageborn, Christine
    Hagstrom, Hannes
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (03) : 273 - 290
  • [3] Update in lean metabolic dysfunction-associated steatotic liver disease
    Sato-Espinoza, Karina
    Chotiprasidhi, Perapa
    Huaman, Mariella R.
    Diaz-Ferrer, Javier
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 452 - 464
  • [4] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):
  • [5] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [6] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [7] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [8] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192
  • [9] From nonalcoholic steatohepatitis, metabolic dys- function-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
    Yeh, Ming-Lun
    Yu, Ming-Lun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (04) : 969 - 972
  • [10] Pediatricians' practices and knowledge of metabolic dysfunction-associated steatotic liver disease: An international survey
    Lubrecht, Judith W.
    van Giesen, Guusje H. J.
    Janczyk, Wojciech
    Zavhorodnia, Olha
    Zavhorodnia, Natalia
    Socha, Piotr
    Moran-Lev, Hadar
    Vreugdenhil, Anita C. E.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (03) : 524 - 533